XML 57 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8

17. RESEARCH AND DEVELOPMENT EXPENSES	9 Months Ended
	Sep. 30, 2014
Notes to Financial Statements
17. RESEARCH AND DEVELOPMENT EXPENSES	The total research and development expenses recognized in the income statements during the three-month and nine-month periods ended September 30, 2014 were $30,985 and $94,322, respectively, of which the consumption of bromine produced by the Company amounted to $8,547 and $26,054, respectively. The total research and development expenses recognized in the income statements during the three-month and nine-month periods ended September 30, 2013 were $33,198 and $105,380, respectively, of which the consumption of bromine produced by the Company amounted to $8,803 and $27,385, respectively.

X

- Details

Name:	gure_NotesToFinancialStatementsAbstract
Namespace Prefix:	gure_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

No authoritative reference available.

+ References

No definition available.

+ Details

Name:	gure_ResearchAndDevelopmentExpensesDisclosureTextblock
Namespace Prefix:	gure_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration